Kirti Kandhwal Chahal
Kirti Kandhwal Chahal
Staff Research Associate
Verified email at ucsd.edu
Title
Cited by
Cited by
Year
The angiotensin receptor blocker losartan suppresses growth of pulmonary metastases via AT1R-independent inhibition of CCR2 signaling and monocyte recruitment
DP Regan, JW Coy, KK Chahal, L Chow, JN Kurihara, AM Guth, ...
The Journal of Immunology 202 (10), 3087-3102, 2019
202019
Hedgehog pathway and smoothened inhibitors in cancer therapies
KK Chahal, M Parle, R Abagyan
Anti-cancer drugs 29 (5), 387-401, 2018
202018
Pharmacokinetics of a fixed-dose combination of atorvastatin and metformin extended release versus concurrent administration of individual formulations
K Kandhwal, S Dey, S Nazarudheen, R Arora, S Reyar, NR Thudi, T Monif, ...
Clinical drug investigation 31 (12), 853-863, 2011
152011
Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?
K Kandhwal, S Dey, S Nazarudheen, S Reyar, S Mishra, NR Thudi, ...
Chirality 23 (10), 948-954, 2011
112011
Combining benefits of an adrenergic and a muscarinic blocker in a single formulation–A pharmacokinetic evaluation
S Nazarudheen, S Dey, K Kandhwal, R Arora, S Reyar, AH Khuroo, ...
Regulatory Toxicology and Pharmacology 67 (2), 226-231, 2013
92013
Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of Naegleria fowleri Sterol Δ8−Δ7-Isomerase and Phenotypic Assays
D Shi, KK Chahal, P Oto, LF Nothias, A Debnath, JH McKerrow, ...
ACS infectious diseases 5 (12), 2029-2038, 2019
32019
Dexamethasone and Fludrocortisone Inhibit Hedgehog Signaling in Embryonic Cells
KK Chahal, M Parle, R Abagyan
ACS omega 3 (9), 12019-12025, 2018
32018
Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma
AR Chahal KK, Li J, Kufareva I, Parle M, Durden DL, Wechsler-Reya RJ, Chen CC
PLOS ONE 14 (9), e0214901, 2019
22019
Orphan receptor GPR37L1 remains unliganded
T Ngo, BP Wilkins, SS So, P Keov, KK Chahal, AM Finch, JLJ Coleman, ...
Nature Chemical Biology 17 (4), 383-386, 2021
2021
Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2
NV Ortiz Zacarías, KK Chahal, T Šimková, C Van Der Horst, Y Zheng, ...
Journal of Medicinal Chemistry 64 (5), 2608-2621, 2021
2021
Orphan G protein-coupled receptor, GPR37L1: pharmacological toolbox empty once again
T Ngo, BP Wilkins, SS So, P Keov, KK Chahal, AM Finch, JLJ Coleman, ...
bioRxiv, 2020
2020
Dynamic Structural Modeling Revealed That Nilotinib Inhibits Smoothened Signaling
KK Chahal, J Li, I Kufareva, D Durden, RW Reya, R Abagyan, CC Chen
Neurosurgery 66 (Supplement_1), nyz310_806, 2019
2019
Multi-target pharmacology of kinase inhibitors, beneficial off-targets and allosteric sites
R Abagyan, I Kufareva, K Chahal, D Shi
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 258, 2019
2019
Orthosteric and allosteric antagonism of chemokine receptors: Structural insights into compound affinity and selectivity
K Chahal, G Baker, Y Zheng, A Tebben, T Handel, I Kufareva
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018
2018
Diphenolic Acid in Plastics Activates Smoothened Receptor
K Kandhwal, I Kufareva, M Parle, R Abagyan
The FASEB Journal 30, 697.3-697.3, 2016
2016
Computationally guided repurposing of approved, multi-targeted therapeutics for smoothened-dependent cancers
K Kandhwal, M Parle, R Abagyan, I Kufareva
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
Bioavailability & Bioequivalence
K Kandhwal
2012
Regulatory recommendations for clopidogrel: Focus on validation of a reliable bioanalytical method and its application to a bioequivalence study
S Dey, K Kandhwal, S Nazarudheen, O Singh, SK Mukherjee, S Mishra, ...
Clinical Research and Regulatory Affairs 28 (4), 87-95, 2011
2011
The system can't perform the operation now. Try again later.
Articles 1–18